Lymphopenia and spleen dose for inoperable pancreatic cancer patients receiving ablative 5-fraction radiation therapy

被引:0
|
作者
Chuong, Michael D.
Herrera, Roberto
Carvallo, Nicolas
Rubens, Muni
Kotecha, Rupesh
Hall, Matthew D.
Mittauer, Kathryn E.
Bassiri-Gharb, Nema
Gutierrez, Alonso N.
Kaiser, Adeel
机构
关键词
D O I
10.1158/1538-7445.PANCA2023-A004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A004
引用
收藏
页数:2
相关论文
共 50 条
  • [31] A multi-institutional randomized phase III trial of chemotherapy alone versus chemotherapy and ablative 5-fraction MRI-guided adaptive radiation therapy for locally advanced pancreatic cancer (LAP-ABLATE)
    Chuong, Michael D.
    Frakes, Jessica M.
    Mittauer, Kathryn E.
    Good, James
    Kim, Josh
    Chang, Daniel
    Kim, Dae Won
    Corradini, Stefanie
    Boldrini, Luca
    Malafa, Mokenge
    O'Reilly, Eileen
    CANCER RESEARCH, 2024, 84 (02)
  • [32] High dose radiation therapy with 3 Gy per fraction in medically inoperable high dose radiation therapy with 3 Gy per fraction in medically inoperable stage I/II non-small cell lung cancer
    Kim, B
    Ahn, YC
    Lim, DH
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S161 - S162
  • [33] High dose radiation therapy with 3 Gy per fraction in medically inoperable high dose radiation therapy with 3 Gy per fraction in medically inoperable stage I/II non-small cell lung cancer
    Ahn, Y
    Kim, B
    Lim, D
    Nam, H
    Oh, D
    Park, Y
    LUNG CANCER, 2005, 49 : S276 - S277
  • [34] Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
    Bryant, J. M.
    Palm, Russell F.
    Herrera, Roberto
    Rubens, Muni
    Hoffe, Sarah E.
    Kim, Dae Won
    Kaiser, Adeel
    Ucar, Antonio
    Fleming, Jason
    De Zarraga, Fernando
    Hodul, Pamela
    Aparo, Santiago
    Asbun, Horacio
    Malafa, Mokenge
    Jimenez, Ramon
    Denbo, Jason
    Frakes, Jessica M.
    Chuong, Michael D.
    CANCER CONTROL, 2023, 30
  • [35] Quality of Life Outcomes for Low- and Intermediate-Risk Prostate Cancer Patients Treated With 5-Fraction Stereotactic Body Radiation Therapy
    Kaplan, I. D.
    Meier, R.
    Beckman, A. C.
    Henning, G.
    Woodhouse, S. A.
    Williamson, S. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E249 - E249
  • [36] Dose Escalation in Locally Advanced Pancreatic Cancer Patients Receiving Chemoradiation Therapy
    Chung, S. Y.
    Chang, J.
    Lee, B. M.
    Kim, K. H.
    Lee, K. J.
    Seong, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S144 - S144
  • [37] Predictors of lymphopenia in esophageal cancer patients receiving photon or proton radiation therapy: A dosimetric analysis.
    Routman, David M.
    Whitaker, Thomas J.
    Day, Courtney N.
    Harmsen, William S.
    Neben-Wittich, Michelle A.
    Haddock, Michael G.
    Hallemeier, Christopher Leigh
    Merrell, Kenneth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [38] Stereotactic body radiation therapy for resectable but medically inoperable pancreatic cancer
    Zhu, X.
    Fuqi, L.
    Dongchen, S.
    Xiaoping, J.
    Yangsen, C.
    Yuxin, S.
    Fei, C.
    Shuiwang, Q.
    Fang, F.
    Zhen, J.
    Huojun, Z.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S772 - S772
  • [39] CA 19-9 Maintains Prognostic Value for Inoperable Pancreatic Cancer Patients Receiving Definitive Hypofractionated or Stereotactic Body Radiation Therapy
    Rudra, S.
    Bommireddy, A.
    Henke, L. E.
    Wang-Gillam, A.
    Kim, H.
    Roach, M. C., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E244 - E244
  • [40] Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results
    Marsha Reyngold
    Parag Parikh
    Christopher H. Crane
    Radiation Oncology, 14